Differentiation in Performance Across the Pharmaceuticals, Animal Health and Other Businesses
A theme concerning divergent performance by business segment in the first quarter of FY2023: the Pharmaceuticals and Animal Health businesses recorded higher revenue and profit, while the Other business recorded lower revenue and a wider loss.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.